help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2115
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/7/2755    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunnari, A.
Right arrow Articles by Kesäniemi, Y. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunnari, A.
Right arrow Articles by Kesäniemi, Y. A.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 7 2755-2760
Copyright © 2006 by The Endocrine Society

High Plasma Resistin Level Is Associated with Enhanced Highly Sensitive C-Reactive Protein and Leukocytes

Anne Kunnari, Olavi Ukkola, Markku Päivänsalo and Y. Antero Kesäniemi

Department of Internal Medicine and Biocenter Oulu (A.K., O.U., Y.A.K.) and Department of Diagnostic Radiology (M.P.), 90014 University of Oulu, Oulu, Finland

Address all correspondence and requests for reprints to: Anne Kunnari, Clinical Research Center/Department of Internal Medicine, P.O. Box 5000, 90014 Oulu University, Oulu, Finland. E-mail: anne.kunnari{at}oulu.fi.

Objectives: Resistin is a newly described hormone with a suggested role in insulin resistance. In humans, inflammatory cells seem to be the major source of resistin. The aim of this study was to find out whether plasma resistin concentration associates with carotid artery atherosclerosis and the risk factors of atherosclerosis.

Methods: Plasma resistin concentrations were measured in 525 Finnish middle-aged subjects among our population-based cohort. Intima-media thickness was measured from the internal carotid artery, the bifurcation enlargement, and the common carotid artery.

Results: Among all the subjects, the median resistin concentration was 7.07 ng/ml (interquartile range, 5.82–8.84), women having higher levels than men (P < 0.001) with median values of 7.56 ng/ml (6.18–9.19) and 6.67 ng/ml (5.63–8.31), respectively. Resistin level correlated negatively with mean intima-media thickness, internal carotid artery, and common carotid artery, but the association did not remain significant after adjustments. Plasma resistin concentration was associated positively with leukocytes (P < 0.001), highly sensitive C-reactive protein (P = 0.009), and IGF binding protein 1 (P < 0.001), but not with plasma insulin or glucose levels in analysis of covariance after adjustments for age, sex, and body mass index.

Conclusions: The results imply that inflammatory factors are more important in the determination of plasma resistin concentration than plasma insulin or glucose values. Resistin is associated with proatherogenic inflammatory markers but not independently with early atherosclerosis.




This article has been cited by other articles:


Home page
QJMHome page
A. Bakhai
Adipokines--targeting a root cause of cardiometabolic risk
QJM, October 1, 2008; 101(10): 767 - 776.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Weikert, S. Westphal, K. Berger, J. Dierkes, M. Mohlig, J. Spranger, E. B. Rimm, S. N. Willich, H. Boeing, and T. Pischon
Plasma Resistin Levels and Risk of Myocardial Infarction and Ischemic Stroke
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2647 - 2653.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. Forsblad d'Elia, R. Pullerits, H. Carlsten, and M. Bokarewa
Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis
Rheumatology, July 1, 2008; 47(7): 1082 - 1087.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Golledge, P. Clancy, K. Jamrozik, and P. E. Norman
Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study
Circulation, November 13, 2007; 116(20): 2275 - 2279.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Ellington, A. R. Malik, G. G. Klee, S. T. Turner, A. D. Rule, T. H. Mosley Jr, and I. J. Kullo
Association of Plasma Resistin With Glomerular Filtration Rate and Albuminuria in Hypertensive Adults
Hypertension, October 1, 2007; 50(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Beauloye, F. Zech, H. Tran Thi Mong, P. Clapuyt, M. Maes, and S. M. Brichard
Determinants of Early Atherosclerosis in Obese Children and Adolescents
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3025 - 3032.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Fantuzzi and T. Mazzone
Adipose Tissue and Atherosclerosis: Exploring the Connection
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
G D Norata, M Ongari, K Garlaschelli, S Raselli, L Grigore, and A L Catapano
Plasma resistin levels correlate with determinants of the metabolic syndrome
Eur. J. Endocrinol., February 1, 2007; 156(2): 279 - 284.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society